Emerging Trends in PBM Restrictions on Commercial Copay Assistance
By Corey Ford, MHA
Xcenda’s Corey Ford, MHA, Director of Reimbursement Strategy and Tactics, teamed with Lash Group’s Jim Dickey, Director of Product Experience, to present a session titled, “Emerging Trends in PBM Restrictions on Commercial Copay Assistance,” at CBI's Reimbursement & Access 2018 conference on August 15, 2018 in Philadelphia. They examined and discussed the emerging copay accumulator trends.
CBI Reimbursement & Access 2018 | Presentation
Emerging Trends in PBM Restrictions on Commercial Copay Assistance
As copay accumulator programs continue to increase, stakeholders look to understand the trends and potential steps forward. Xcenda's Corey Ford, MPH, Director of Reimbursement Strategy and Tactics, along with Jim Dickey, Director of Product Experience at Lash Group, discussed the evolution and advancement in payer tactics to manage specialty drugs.
They examined the emerging payer restrictions on copay assistance programs, discussed manufacturer considerations and potential solutions, looked at the impact on patients, providers, and patient support programs, and closed the discussion with a case study. To view the presentation, please click below.
They examined the emerging payer restrictions on copay assistance programs, discussed manufacturer considerations and potential solutions, looked at the impact on patients, providers, and patient support programs, and closed the discussion with a case study. To view the presentation, please click below.
